Abstract
The effects of prenatal THC administration, given during the third week of gestation in rats, on the reproductive, endocrine and immune systems of the adult offspring were examined. THC treatment blocked the surge of testosterone which occurs in the male rat fetus on gestation day 18. Moreover, when copulatory parameters were measured in adult male offspring, males that had been exposed to THCin utero exhibited an increased latency to mount (THC: 245±49vs vehicle: 99±12 sec) and none of the males ejaculated. Female rats exposed to THCin utero, exhibited an increased incidence of irregular estrous cycles and the number of females exhibiting lordosis behavior was reduced when compared to vehicle controls. Hormone analyses revealed that prolactin levels were significantly lower in the THC-vs vehicle-exposed male (THC: 5.2±0.4vs vehicle: 8.4±0.6 ng/ml) and female offspring (THC: 5.7±0.3vs vehicle: 12.2±1.8 ng/ml). However, there were no significant differences in basal plasma LH levels or in testicular weights of the male offspring. Thymus weight and total number of thymocytes were significantly higher in THC-exposed male and female rats when compared to vehicle controls. Together, these results indicate that maternal THC exposure has long-lasting effects on reproductive, endocrine and immune parameters of both male and female rat offspring.
Similar content being viewed by others
References
Asch, R.H., Smith, C.G., Siler-Khodr, T.M. & Pauerstein, C.J. (1979).Fertil. Steril.,32: 571–575.
Bateman, A., Singh, A., Kral, T., Solomon, S. (1989).Endo. Rev.,10, 91–112.
Besch, N.F., Smith, C.G., Besch, P.K. & Kaufmann, R.H. (1977).Am. J. Obstet. Gynecol.,128, 635–642.
Besedovsky, H.O. & Sorkin, E. (1974).Nature,249, 356–358.
Blair, P.B. (1981). In:Developmental Effects of Diethylstibestrol (DES) in Pregnancy. Herbst, A. L., Bern, H. A. (eds.). Thieme-Stratton Inc.: New York, pp. 167–78.
Blanchard, D.K., Newton, C., Klein, T.W., Stewart, W.E. II & Friedman, H. (1986).Int J Immunopharmacol.,8, 819–824.
Cabral, G.A., Mishkin, E.M., Marciano-Cabral, F., Coleman, P., Harris, L. & Munson, A.E. (1986).Proc. Soc. Exp. Biol. Med.,182, 181–186.
Chandrashekar, V., Bartke, A. & Sellers, K. (1987).Endocrinology,120, 758–763.
Daltario, S.L. (1980).Pharmacol. Biochem. Behav.,12, 143–153.
Dalterio, S. & Bartke, A. (1981).J. Endocrinol.,91, 509–514.
Dalterio, S.L., Steger, R., Mayfield, D. & Batke, A. (1984).Pharmacol. Biochem. Behav.,20, 107–113.
Dalterio, S.L., Steger, R., Mayfield, D. & Bartke, A. (1984a).Pharmacol. Biochem. Behav.,20, 115–123.
Dalterio, S., Thomford, P.J., Michael, S.D., DeAngelo, L. & Mayfield, D. (1986).Teratology,33, 195–201.
Daul, C.B. & Heath, R.G. (1975).Life Sci.,17, 875–882.
Dewey, W.L., Peng, T.C. & Harris, L.S. (1970).Eur. J. Pharmacol.,12, 382–384.
Gher, J. (1992). Master's Thesis, Southern Illinois University.
Gorski, R.A. (1971). In:Frontiers in Neuroendocrinology. Martini, L., Ganong, W.F. (eds.). Oxford University Press: New York. pp. 237–90.
Grossman, C.J., Sholiton, L.J. & Roselle, G.A. (1982).J. Steroid Biochem.,16, 683–690.
Grossman, C.J. (1984).Endo Rev.,5, 435–455.
Harbison, R.D., Mantilla-Plata, B. (1972).J. Pharmacol. Exp. Ther.,180, 446–453.
Hardy, D.F. & Debold, J.F. (1971).Physiol. Behav.,7, 643–645.
Healy, D.L., Hodgen, G.D., Schulte, H.M., Chrousos, G.P., Loriaux, D.L., Hall, N.R. & Goldstein, A.L. (1983).Science,2222, 1353–1355.
Herrenkohl, L.R. (1979).Science,206, 1097–1099.
Hughes, C.L. Jr, Everett, J.W. & Tyrey, L. (1981).Endocrinology,109, 876–880.
Jakubovic, A., McGeer, E.G. & McGeer, P.L. (1979). In:Marihuana: Biological Effects. Nahas, G.G., Paton, W.D. (eds.). Pergamon Press: New York. pp. 251–64.
Kalland, T., Fossberg, T.M. & Forsberg, J.G. (1978).Exper. Molec. Path.,28, 76–80.
Kaminiski, N.E., Abood, M.E., Kessler, F.K., Martin, B.R. & Schatz, A.R. (1992).Mol. Pharmacol.,42, 736–742.
Klein, T.W., Kawakami, Y., Newton, C. & Friedman, H. (1991).J. Toxicol. Environ. Health.,32, 465–477.
Kolodny, R.C., Masters, W.H., Kolodny, R.M. & Toro, G. (1974).N. Engl. J. Med.,290, 872–874.
Kramer, J. & Ben-David, M. (1978).Endocrinology,103, 452–457.
Kumar, A.M., Solomon, J., Patel, V., Kream, R.M., Drieze, J.M. & Millard, W.J. (1986).Neuroendocrinology,44, 260–264.
Laceta, J., Fernandez-Gala, C., Sanchez, C., Navarro, R., Gomariz, R.P., Zapata, A. & Tejero, A. (1988).Dev. Comp. Immunol.,12,
Luster, M.I., Faith, R.E., McLachlan, J.A. & Clark, C.G. (1979).Toxicol. Appl. Pharmacol.,47, 279–285.
Marks, B.H. (1973).Prog. Brain Res.,39, 331–338.
McLusky, N.J. & Naftolin, F. (1981).Science,211, 1294–1303.
Mendelson, J.H., Mello, N.K. & Ellingboe, J. (1985).J. Pharmacol. Exp. Ther.,232, 220–222.
Mendelson, J.H., Mello, N.K., Ellingboe, J., Skupny, A.S.T., Lex, B.W. & Griffin, M. (1986).J. Pharmacol. Exp. Ther.,237, 862–866.
Michael, S.D., Taguchi, O. & Nishizuka, Y. (1980).Biol. Reprod.,22, 343–350.
Morahan, P.S., Klykken, P.C., Smith, S.H., Harris, L.S. & Munson, A.E. (1979).Infect. Imm.,23, 670–674.
Murphy, L.L. & Tyrey, L. (1986).Neuroendocrinology,43, 471–475.
Murphy, L.L., Steger, R.W., Smith, M.S. & Bartke, A. (1990).Neuroendocrinology,52, 316–321.
Murphy, L.L., Steger, R.W. & Bartke, A. (1990a). In:Biochemistry and Physiology of Substance Abuse, Vol. II. Watson, R.R. (ed.) CRC Press, Inc.: Boca Raton, pp. 73–93.
Murphy, L.L., Newton, S.C., Dhali, J. & Chávez, D. (1991).Pharmacol. Biochem. Behav.,40, 603–607.
Murphy, L.L., Gher, J., Steger, R.W. & Bartke, A. (1994).Pharmacol. Biochem. Behav.,48, 1011–1017.
Nishizuka, Y. & Sakakura, T. (1971).Endocrinology,89, 886–893.
Petersen, B.H., Graham, J., Lemberger, L. & Dalton, B. (1974).Pharmacologist,16, 259.
Petersen, B.H., Graham, J. & Lemberger, L. (1976).Life Sci.,19, 395–400.
Pross, S.H., Klein, T.W., Newton, C.A. & Friedman, H. (1987).Int. J. Immunopharm.,9, 363–370.
Reinisch, J. (1974).Arch. Sex Behav.,3, 51–90.
Rivier, C. & Rivest, S. (1991).Biol. Reprod.,45, 523–532.
Rodríguez de Fonseca, F., Cebeira, M., Fernández-Ruiz, J.J., Navarro, M. & Ramos, J.A. (1991).Neuroscience,43, 713–723.
Rodríguez de Fonseca, F., Murphy, L.L., Bonnin, A., Eldridge, J.C., Bartke, A. & Fernandez-Ruiz, J.J. (1992).Neuroendocrinol. (Life Sci. Adv.),11, 147–156.
Smith, C.G., Moore, C.E., Besch, N.F. & Besch, P.K. (1976).Clin. Chem.,22, 1184–1186.
Smith, C.G., Almirez, R.G., Berenberg, J. & Asch, R.H. (1983).Science,219, 1453–1455.
Solomon, J., Cocchia, M., Gray, R., Shattuck, D. & Vossner, A. (1975).Science,192, 559–561.
Steger, R.W., Murphy, L.L., Bartke, A. & Smith, M.S. (1990).Pharmacol. Biochem. Behav.,37, 299–302.
Tyrey, L. (1978).Endocrinology,102, 1808–1814.
Walters, D.E. & Carr, L.A. (1986).Pharmacol. Biochem. Behav.,25, 763–768.
Weidenfield, J., Feldman, S. & Mechoulam, R. (1994).Neuroendocrinology,59, 110–112.
Wenger, T., Croix, D., Tramu, G. & Leonardelli, J. (1992). In:Marijuana/Cannabinoids: Neurobiology and Neurophysiology. Murphy, L.L., Bartke, A. (eds.) CRC Press, Inc.: Boca Raton, pp. 539–560.
Wilson, J.D., Griffin, J.E., George, F.W. & Lesbin, M. (1983).Australian J. of Biol. Sci.,36, 101–128.
Zimmerman, S., Zimmerman, A.M., Cameron, I.L. & Laurence, H.L. (1977).Pharmacol.,15, 10–23.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Murphy, L.L., Gher, J. & Szary, A. Effects of prenatal exposure to delta-9-tetrahydrocannabinol on reproductive, endocrine and immune parameters of male and female rat offspring. Endocr 3, 875–879 (1995). https://doi.org/10.1007/BF02738892
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02738892